Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity 2022-06-08
Ovarian cancer is one of the most malignant gynecological cancers with a 5-year survival rate of only about 48% (Kuroki and Guntupalli, 2020). For advanced-stage ovarian cancer, debulking surgery combined with platinum-based chemotherapy is still the main treatment strategy (Matulonis et al., 2016).
Read More 
